Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

IBEX Technologies

IBEX Technologies
PUBLIC STATUS
1-10 EMPLOYEES
IBT STOCK SYMBOL
3 INVESTMENTS
$0.08 SHARE PRICE (As of Friday Closing)
Description

Ibex Technologies Inc is a Canada based company engaged in production and sale of diagnostic products. The company manufactures and markets enzymes for biomedical use, through its subsidiaries. In addition, it also manufactures and markets a series of arthritis assays which have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, U.S, U.K, and other countries of which majority of the revenue is generated from the U.S.

Website
Formerly Known As
Continental Pharma Cryosan
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Medical Supplies
Stock Exchange
TSX
Primary Office
  • 5485 Pare Street
  • Suite 100
  • Montreal, Quebec H4P 1P7
  • Canada

+1 (514) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore IBEX Technologies’s full profile, request a free trial.

IBEX Technologies Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.07 - $0.19 $2.07M $0.09 -$0.02 10.4K 24.8M

IBEX Technologies Financials Summary

In Thousands,
USD
TTM
30-Apr-2019
FY 2018
31-Jul-2018
FY 2017
31-Jul-2017
FY 2016
31-Jul-2016
Enterprise Value 1,006 3,744 3,501 622
Revenue 3,343 3,713 4,022 3,095
EBITDA (240) 246 648 374
Net Income (534) (75) 2,251 76
Total Assets 6,606 7,250 7,650 4,932
Total Debt 763 795 836 871
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IBEX Technologies Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore IBEX Technologies‘s full profile, request access.

Request full access to PitchBook

IBEX Technologies Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000-00000000 00000 02-Jan-2013 000000000000000000 000 Other Pharmaceuticals and Biotechnology
00000000 28-Apr-2007 000000000000000000 00.000 Personal Products 0000 00000
OncoTherapeutics 08-May-2003 Merger/Acquisition 00000 Drug Discovery 0000 00000
To view this company’s complete investment and acquisition history, request access »

IBEX Technologies Subsidiaries (2)

Company Name Industry Location Founded
OncoTherapeutics Drug Discovery West Hollywood, CA 1992
000-00000000 00000 Other Pharmaceuticals and Biotechnology North Liberty, IA 0000
To view this company’s complete subsidiary history, request access »

IBEX Technologies Executive Team (2)

Name Title Board
Seat
Contact
Info
Paul Baehr Chief Executive Officer & Chairman

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »

IBEX Technologies Board Members (3)

Name Representing Role Since Contact
Info
0000 00000 IBEX Technologies Chief Executive Officer & Chairman 000 0000

2 Former Board Members

You’re viewing 1 of 3 board members. Get the full list »